Top Markets
Coin of the day
Novartis AG Novartis AG

Novartis AG

NVS
주식 순위 #46
Novartis AG researches, develops, manufactures, and markets healthcare products... Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatology, respiratory, cardiovascular, renal, and metabolism medicine products. The Sandoz segment develops, manufactures, and markets finished dosage form medicines; active ingredients and finished dosage forms of small molecule pharmaceuticals to third parties; and retail generics and anti-infectives. It also provides active pharmaceutical ingredients and intermediates primarily antibiotics; protein- or other biotechnology-based products, including biosimilars; and biotechnology manufacturing services. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran; and a clinical collaboration with Kura Oncology, Inc. to evaluate the combination of Tipifarnib and Alpelisib in patients with head and neck squamous cell carcinoma. The company was incorporated in 1996 and is headquartered in Basel, Switzerland.
주가
$150.75
시가총액
$291.41B
변동 (1일)
1.44%
변동 (1년)
40.17%
국가
CH
거래 Novartis AG (NVS)

카테고리

Novartis AG (NVS)의 주가 이력
최고 종가: $155.94 (2026-03-01 기준)

최저 종가: $37.62 (2007-07-01 기준)
Novartis AG의 주가 이력 (2007 ~ 2026)
연간 주가 성과
연도 성과
2026 (TTM) -3.28%
2025 34.10%
2024 0.80%
2023 8.18%
2022 8.56%
2021 -8.53%
2020 -1.85%
2019 7.02%
2018 3.37%
2017 19.27%
2016 -17.95%
2015 -9.05%
2014 20.00%
2013 24.86%
2012 12.90%
2011 -2.17%
2010 51.10%
2009 16.08%
2008 -15.89%
2007 0.00%
유사 기업 또는 경쟁사의 주가
회사 주가 변동률 1년% 국가
$916.42 10.84%
US
$187.14 157.34%
GB
$239.93 48.36%
US
$207.15 2.91%
US
$119.37 35.48%
US